PMID: 40572Jan 1, 1978

The effects of repeated doses of temazepam taken in conjunction with alcohol on aspects of psychomotor performance the morning following night time medication

Arzneimittel-Forschung
Ian Hindmarch

Abstract

A study to compare the morning-after effects of three dose levels of temazepam (Euhypnos capsules) given with alcohol, was carried out in 18 healthy volunteers. Matched placebos were given for two days before and four days after the four nights on active drug and a standard dose of alcohol was given on all ten nights of the study. Objective measurements made on the mornings after days 2, 4, 6 and 10 were critical flicker fusion threshold (CFF), choice reaction time (CRT) and digit symbol substitution tasks (DSST). The administration of 10 or 20 mg temazepam with alcohol produced no significant change inany of these measurements. 30 mg produced no change in DSST and although there was some impairment of CRT at this dose, it was not statistically significant. The combination of 30 mg temazepam and alcohol significantly depressed CFF following four nights on these drugs.

Related Concepts

Ethanol
Motor Skills
Reaction Time
Depressed - Symptom
Anti-Anxiety Effect
Drug Interactions
Flicker Fusion
Night Time brand of acetaminophen, dextromethorphan, doxylamine, and pseudoephedrine
Benzodiazepines
Temazepam

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.